BioSpace News Archive

SES Direct to Streamline Communications Across Their Network

Narcolepsy Network, the leading nonprofit organization that is dedicated to increasing early diagnosis of narcolepsy, advocating for and supporting persons with narcolepsy and their families, and promoting critical research for treatment and a cure, has partnered with 22 national and international organizations to establish World Narcolepsy Day.

Neogen Corporation (NASDAQ: NEOG) announced today that it has signed a development and licensing agreement with Corvium, Inc., that will allow Neogen’s customers exclusive access to an enhanced version of Corvium’s award-winning CONTROL-PRO™ food risk intelligence platform.

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Tuesday, September 10, 2019, at 8:30 a.m. Eastern Time to review the Company’s fiscal second quarter 2020 financial results.

ROAR Organic, the USDA Certified Organic electrolyte infusion with antioxidants and B-vitamins, today announces its ‘ROAR Models’ digital campaign.

Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced that it completed the acquisition of Glendale Greenhouse, a vertically integrated cannabis business in Arizona.

On October 18, 2019, thousands of people across the U.S. will show their support for those affected by cancer and raise money for cancer charities as a part of National Be Bold, Be Bald! Day.

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has completed enrollment in the company’s open-label, 24 patient, Phase 2 trial with its lead immunotherapy product VGX-3100 in patients with precancerous lesions of the anus, i.e. anal high-grade squamous intraepithelial lesions (anal HSIL, aka anal intraepithelial neoplasia)

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) is pleased to announce today that its board of directors has appointed Toni Rinow as Chief Executive Officer and Dr. Renz as Regional Manager Europe in addition to serving as its Chief Medical Officer.

Phase 2 Expansion More Than Doubles Company’s Florida Cultivation Output